Market Overview:
The global leukotriene modifiers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, rising awareness about leukotriene modifiers and their benefits, and the launch of novel products. Based on type, the global leukotriene modifiers market is segmented into tablets, chewable tablets, and oral granules. The chewable tablet segment is expected to grow at a higher CAGR than other segments during the forecast period owing to its ease of use and convenience. By application, hospitals pharmacies accounted for the largest share of the global leukotriene modifiers market in 2017; however, retail pharmacies are projected to grow at a higher rate during the forecast period.
Product Definition:
Leukotriene modifiers are a class of medications used to prevent and treat asthma and other respiratory conditions. They work by blocking the effects of leukotrienes, chemicals that can cause inflammation in the lungs. Leukotriene modifiers are important for asthma treatment because they can help reduce inflammation in the lungs, making it easier to breathe.
Tablets:
Tablets, it's usage.
Leukotriene modifiers are used to prevent or reduce the inflammatory response caused by certain compounds found in foods (such as eggs, fish, meat), drugs (aspirin and other pain-relieving drugs), chemical irritants (sulfuric acid and nitric acid) as well as environmental factors such as pollution.
Chewable Tablets:
Chewable tablets are small sized solid dose medications that can be easily divided into appropriate doses for daily use. Chewable tablets are usually formulated with the main active ingredient and may contain excipients (such as binders, disintegrants, and fillers) which help in rapid absorption of the drug.
Application Insights:
The market is segmented by application into hospitals, pharmacies, drug stores and online pharmacies. The hospitals segment dominated the global leukotriene modifiers market in 2017 owing to increasing prevalence of chronic diseases such as asthma and allergies. In addition, growing awareness about available treatment options coupled with rising availability of healthcare facilities is expected to drive growth over the forecast period.
The drug stores application segment was valued at USD 544.3 million in 2017 owing to high product demand from patients seeking cost-effective treatment for various chronic conditions such as arthritis and cancer pain without insurance coverage or government reimbursement.
Regional Analysis:
North America was the largest regional market in 2017 owing to high consumer awareness and presence of key manufacturers. The region is expected to maintain its dominance over the forecast period due to increasing product demand for treatment of various skin disorders, such as eczema and psoriasis. Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 on account of rising disposable income levels, improving healthcare infrastructure, growing pharmaceutical industry coupled with government initiatives pertaining health benefits associated with leukotrienes. In addition, increasing prevalence of chronic diseases such as asthma will drive product demand in this region.
In October 2016, Sun Pharmaceutical Industries Ltd., India based generic drug manufacturer filed patent application for Leukotriene Modulator tablets containing bupropion under brand name Wellbutrin which are used for smoking cessation therapy (nicotine replacement therapy).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global Leukotriene Modifiers market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis.
- Growing awareness about leukotriene modifiers: There is a growing awareness among people about the benefits of leukotriene modifiers in preventing and managing respiratory diseases. This is expected to drive the growth of the Leukotriene Modifiers market during the forecast period.
- Technological advancements in leukotriene modifier drugs: The development of novel technologies for manufacturing leukotriene modifier drugs is expected to fuel the growth of this market during the forecast period. For instance, In 2012, AstraZeneca received approval from US FDA for its drug Xolair (omalizumab) for treating moderate-to-severe persistent asthma in adults and children aged six years and older who are not adequately controlled with inhaled corticosteroids alone4 . Such technological advancements are likely to boost demand for Leukotrienes Modifier drugs in coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Leukotriene Modifiers Market Research Report
By Type
Tablets, Chewable Tablets, Oral Granules
By Application
Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
By Companies
AstraZeneca PLC, GlaxoSmithKline, Chiesi Farmaceutici, Merck, Starallergens Greer, Sumitomo Dainippon Pharma, Circassia Pharmaceuticals, Apotex Holdings, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, annett Company, Novartis, Aurobindo Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Leukotriene Modifiers Market Report Segments:
The global Leukotriene Modifiers market is segmented on the basis of:
Types
Tablets, Chewable Tablets, Oral Granules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca PLC
- GlaxoSmithKline
- Chiesi Farmaceutici
- Merck
- Starallergens Greer
- Sumitomo Dainippon Pharma
- Circassia Pharmaceuticals
- Apotex Holdings
- Teva Pharmaceutical Industries
- Torrent Pharmaceuticals
- annett Company
- Novartis
- Aurobindo Pharma
Highlights of The Leukotriene Modifiers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Chewable Tablets
- Oral Granules
- By Application:
- Hospitals Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Leukotriene Modifiers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Leukotriene modifiers are medications that help to control inflammation. They can be used in the treatment of conditions such as asthma, COPD, and arthritis.
Some of the major companies in the leukotriene modifiers market are AstraZeneca PLC, GlaxoSmithKline, Chiesi Farmaceutici, Merck, Starallergens Greer, Sumitomo Dainippon Pharma, Circassia Pharmaceuticals, Apotex Holdings, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, annett Company, Novartis, Aurobindo Pharma.
The leukotriene modifiers market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Leukotriene Modifiers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Leukotriene Modifiers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Leukotriene Modifiers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Leukotriene Modifiers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Leukotriene Modifiers Market Size & Forecast, 2018-2028
4.5.1 Leukotriene Modifiers Market Size and Y-o-Y Growth
4.5.2 Leukotriene Modifiers Market Absolute $ Opportunity
Chapter 5 Global Leukotriene Modifiers Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Leukotriene Modifiers Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Chewable Tablets
5.2.3 Oral Granules
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Leukotriene Modifiers Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Leukotriene Modifiers Market Size Forecast by Applications
6.2.1 Hospitals Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Drug Stores
6.2.4 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Leukotriene Modifiers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Leukotriene Modifiers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Leukotriene Modifiers Analysis and Forecast
9.1 Introduction
9.2 North America Leukotriene Modifiers Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Leukotriene Modifiers Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Chewable Tablets
9.6.3 Oral Granules
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Leukotriene Modifiers Market Size Forecast by Applications
9.10.1 Hospitals Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Drug Stores
9.10.4 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Leukotriene Modifiers Analysis and Forecast
10.1 Introduction
10.2 Europe Leukotriene Modifiers Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Leukotriene Modifiers Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Chewable Tablets
10.6.3 Oral Granules
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Leukotriene Modifiers Market Size Forecast by Applications
10.10.1 Hospitals Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Drug Stores
10.10.4 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Leukotriene Modifiers Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Leukotriene Modifiers Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Leukotriene Modifiers Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Chewable Tablets
11.6.3 Oral Granules
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Leukotriene Modifiers Market Size Forecast by Applications
11.10.1 Hospitals Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Drug Stores
11.10.4 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Leukotriene Modifiers Analysis and Forecast
12.1 Introduction
12.2 Latin America Leukotriene Modifiers Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Leukotriene Modifiers Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Chewable Tablets
12.6.3 Oral Granules
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Leukotriene Modifiers Market Size Forecast by Applications
12.10.1 Hospitals Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Drug Stores
12.10.4 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Leukotriene Modifiers Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Leukotriene Modifiers Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Leukotriene Modifiers Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Chewable Tablets
13.6.3 Oral Granules
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Leukotriene Modifiers Market Size Forecast by Applications
13.10.1 Hospitals Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Drug Stores
13.10.4 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Leukotriene Modifiers Market: Competitive Dashboard
14.2 Global Leukotriene Modifiers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca PLC
14.3.2 GlaxoSmithKline
14.3.3 Chiesi Farmaceutici
14.3.4 Merck
14.3.5 Starallergens Greer
14.3.6 Sumitomo Dainippon Pharma
14.3.7 Circassia Pharmaceuticals
14.3.8 Apotex Holdings
14.3.9 Teva Pharmaceutical Industries
14.3.10 Torrent Pharmaceuticals
14.3.11 annett Company
14.3.12 Novartis
14.3.13 Aurobindo Pharma
